The efficacy of bevacizumab combined with erlotinib (B + E) for the treatment of advanced hepatocellular carcinoma, especially for sorafenib-refractory patients, has been observed and evaluated in several trials. | Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma A single-arm meta-analysis based on prospective studies